December 10, 2020 – B. Braun Medical Inc. (Bethlehem, PA) announced it has received FDA approval for use of Cefazolin for Injection and Dextrose Injection 1gm and 2gm in Duplex in pediatric patients.
The DUPLEX Drug Delivery System is a ready-to-use dual-Chamber IV bag designed to simplify intravenous antibiotic delivery to patients, minimize the potential for medication errors, and help eliminate the pharmacy labor component of IV antibiotic delivery and reduce drug waste.
A post-market requirement (PMR) safety study was conducted in pediatric patients. This drug is now approved for treatment of infections in pediatric patients and for perioperative prophylaxis in patients age 10 to 17.